Related Experiment Video
Updated: Sep 9, 2025

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
4.2K
Mitochondria: Key Mediator for Environmental Toxicant-Induced Neurodegeneration
Nishi Shah1, Bhagawati Saxena1, Richa Gupta1
1Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, India.
International Journal of Toxicology
|August 28, 2025
Summary
Environmental toxicants like heavy metals and pesticides contribute to neurodegenerative diseases by damaging mitochondria. Targeting mitochondrial dysfunction offers a promising therapeutic strategy for conditions such as Alzheimer's and Parkinson's disease.
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- Environmental toxicants are implicated in neurodegenerative diseases like Alzheimer's and Parkinson's.
- Mitochondrial dysfunction is increasingly recognized as a critical factor in disease progression.
- Neurons are particularly vulnerable due to their high energy demands.
Purpose of the Study:
- To review the role of mitochondria in environmental toxicant-induced neurodegeneration.
- To highlight how environmental exposures lead to mitochondrial dysfunction.
- To explore mitochondria as a therapeutic target for neuroprotection.
Main Methods:
- Literature review of studies on environmental toxicants and neurodegeneration.
- Analysis of mechanisms linking toxicant exposure to mitochondrial impairment.
- Synthesis of evidence on mitochondrial dysfunction in disease pathogenesis.
Main Results:
- Environmental toxicants impair mitochondrial membranes, disrupt the electron transport chain, and increase oxidative stress.
- Toxicant-induced mitochondrial damage, including DNA damage and fragmentation, accelerates neurodegeneration.
- Dysfunctional mitochondria are central to the progression of neurodegenerative disorders.
Conclusions:
- Mitochondrial dysfunction is a key mechanism in environmental toxicant-induced neurodegeneration.
- Targeting mitochondria presents a rational approach for developing disease-modifying therapies.
- Understanding these pathways is crucial for identifying risk factors and designing interventions.
Related Concept Videos
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Mitochondria
14.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.9K
Mitochondrial Membranes
12.3K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
12.3K
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Translocation of Proteins into the Mitochondria
3.2K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.2K

